|
| |
Press Releases
Study Shows IVIG Safe, Effective Treatment for Muscle DiseaseWednesday, December 29, 1993Patients with a painful and debilitating muscle disease called dermatomyositis showed dramatic improvement on a treatment regimen of intravenous immune globulin (IVIG) during a recent double-blind, placebo-controlled trial. The study, which was conducted at the National Institute of Neurological Disorders and Stroke (NINDS), will be published in the December 30 issue of the New England Journal of Medicine.
Fact Sheet
|
|
